While MediWound Ltd has overperformed by 3.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MDWD rose by 7.08%, with highs and lows ranging from $22.50 to $14.14, whereas the simple moving average jumped by 4.06% in the last 200 days.
On June 02, 2025, Oppenheimer started tracking MediWound Ltd (NASDAQ: MDWD) recommending Outperform. A report published by Alliance Global Partners on May 02, 2025, Initiated its previous ‘Buy’ rating for MDWD. Craig Hallum also rated MDWD shares as ‘Buy’, setting a target price of $39 on the company’s shares in an initiating report dated February 28, 2025. Maxim Group Reiterated the rating as Buy on July 16, 2024, but set its price target from $25 to $30. Maxim Group initiated its ‘Buy’ rating for MDWD, as published in its report on December 22, 2022. Oppenheimer’s report from July 18, 2022 suggests a price prediction of $7 for MDWD shares, giving the stock a ‘Outperform’ rating. BTIG Research also rated the stock as ‘Buy’.
Analysis of MediWound Ltd (MDWD)
Further, the quarter-over-quarter increase in sales is 12.74%, showing a positive trend in the upcoming months.
In order to gain a clear picture of MediWound Ltd’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -148.65% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.35, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 81.72K can be a very valuable indicator of volatility for MDWD stock. On a monthly basis, the volatility of the stock is set at 4.95%, whereas on a weekly basis, it is put at 7.95%, with a gain of 13.72% over the past seven days. Furthermore, long-term investors anticipate a median target price of $30.50, showing growth from the present price of $19.06, which can serve as yet another indication of whether MDWD is worth investing in or should be passed over.
How Do You Analyze MediWound Ltd Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 31.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 33.59% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
